Skip to main content Back to Top
Advertisement

5/16/2022

Metronidazole Hydrochloride Injection

Products Affected - Description

    • Metronidazole hydrochloride solution for injection, BBraun, 5 mg/mL, 100 mL bag, 24 count, NDC 00264-5535-32
    • Metronidazole hydrochloride solution for injection, Baxter, 5 mg/mL, 100 mL bag, 24 count, NDC 00338-1055-48
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 24 count, NDC 00409-7811-24
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 80 count, NDC 00409-7811-37
    • Metronidazole hydrochloride solution for injection, Sagent, 5 mg/mL, 100 mL bag, 24 count, NDC 25021-0131-82

Reason for the Shortage

    • Baxter has metronidazole injection on shortage due to increased demand.
    • BBraun has metronidazole injection on shortage due to manufacturing delays with raw materials.
    • Pfizer has metronidazole injection on shortage due to increased demand.
    • Sagent did not provide a reason for the shortage.

Available Products

    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 24 count, NDC 00409-0152-24

Estimated Resupply Dates

    • Baxter has metronidazole 5 mg/mL 100 mL bags on allocation.
    • BBraun has metronidazole 5 mg/mL 100 mL bags on allocation.
    • Pfizer has metronidazole 5 mg/mL 100 mL bags in 24 count (NDC 00409-7811-24) are on back order and the company estimates a release date of May 2022. The metronidazole 5 mg/mL 100 mL bags in 80 count are on back order and the company estimates a release date of June 2022.
    • Sagent has metronidazole 5 mg/mL 100 mL bags on a limited allocation.

Updated

Updated May 16, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 20, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.